[pending] LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE ANHYDROUS)
Pending LLM rewrite. Source: FDA_DRUG D-0554-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Lack of Assurance of Sterility
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE ANHYDROUS)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Spectra Medical Devices, Llc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: AE4013
- Exp 1/31/2027
- AE5032 & AE5039
- Exp 3/31/2028
- AE5104
- Exp 8/31/2028.
UPCs (1)
- 0365282160515
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- HighLidocaine Hydrochloride Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-04-22
- HighLidocaine Hydrochloride Injection Recalled Nationwide for Sterility Assurance Issues
FDA (Drugs) · 2026-04-22
- SevereLidocaine injection recalled due to glass particulate matter
FDA (Drugs) · 2023-11-15
- SeverePfizer Lidocaine Injection Recall: Glass Particulates in Injectable Medication
FDA (Drugs) · 2023-11-15
- SevereLidocaine Hydrochloride Topical Solution recalled for being superpotent
FDA (Drugs) · 2022-01-05
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27